Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets

Molecular Imaging

Volumn 1, Issue 1, 2002, Pages 16-23

  Bogdanov Jr , Alexei ^a   Matuszewski, Lars ^a   Bremer, Christoph ^a   Petrovsky, Alexander ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

DOTA; Gadolinium; Magnetic resonance imaging; Oxidoreductases; Peroxidase; Signal amplification

Indexed keywords

AMPLIFICATION; ELECTRONS; ENZYMES; MAGNETIC RESONANCE IMAGING; OPTICAL RESOLVING POWER; RARE EARTH ELEMENTS;

MOLECULAR TARGETS;

MEDICAL IMAGING;

HETEROCYCLIC COMPOUND;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; IMAGE ENHANCEMENT; IMAGE PROCESSING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

HETEROCYCLIC COMPOUNDS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SENSITIVITY AND SPECIFICITY;

EID: 0002808589     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002753395671     Document Type: Article

References (38)

1. Weber DA, Ivanovic M (1999). Ultra-high-resolution imaging of small animals: Implications for predinical and research studies. J Nucl Cardiol. 6:332-344.
2. Paulus MJ, Gleason SS, Kennel SJ, Hunsicker PR, Johnson DK (2000). High resolution X-ray computed tomography: An emerging tool for small animal cancer research. Neoplasia. 2:62-70.
3. Phelps ME (2000). Positron emission tomography provides molecular imaging of biological processes, Proc Natl Acad Sci USA, 97:9226-9233.
4. Kornblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR (2000). In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET): Nat Biotechnol, 18:655-660.
5. Smith BR, Johnson GA, Groman EV, Linney E (1994). Magnetic resonance microscopy of mouse embryos. Proc Natl Acad Sci USA. 91:3530-3533.
6. Hesselbarth D, Franke C, Hata R, Brinker G, Hoehn-Berlage M (1998). High resolution MRI and MRS: A feasibility study for the investigation of focal cerebral ischemia in mice. NMR Biomed. 11:423-429.
7. Ugurbil K, Hu X, Chen W, Zhu XH, Kim SG, Georgopoulos A (1999). Functional mapping in the human brain using high magnetic fields. Philos Trans R Soc London, Ser B. 354:1195-1213.
8. Ruff J, Wiesmann F, Hiller KH, Voll S, von Kienlin M, Bauer WR, Rommel E, Neubauer S, Haase A (1998). Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med. 40:43-48.
9. Kooy RF, Reyniers E, Verhoye M, Sijbers J, Bakker CE, Oostra BA, Willems PJ, Van Der Linden A (1999). Neuroanatomy of the fragile X knockout mouse brain studied using in vivo high resolution magnetic resonance imaging, Eur J Hum Genet. 7:526-532.
10. Dubowitz DJ, Tyszka JM, Sewry CA, Moats RA, Scadeng M, Dubowitz V (2000). High resolution magnetic resonance imaging of the brain in the dy/dy mouse with merosin-deficient congenital muscular dystrophy. Neuromuscular Dis. 10:292-298.
11. Jacobs RE, Ahrens ET, Meade TJ, Fraser SE (1999). Looking deeper into vertebrate development, Trends Cell Biol. 9:73-76.
12. Suite JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA (1999). Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA. 96:15256-15261.
13. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000). Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Gen. 9:195-202.
14. Ranney DF (2000). Biomimetic transport and rational drug delivery. [Review] [91 refs]. Biochem Pharmacol. 59:105-114.
15. Weissleder R, Bogdanov A, Papisov M (1992). Drug targeting in magnetic resonance imaging. Magn Res Q. 8:55-63.
16. Nunn AD, Linder KE, Tweedle MF (1997), Can receptors be imaged with MRI agents? Q J Nucl Med. 41:155-162.
17. Kayyem JF, Kumar RM, Fraser SE, Meade TJ (1995). Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem Biol. 2:615-620.
18. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP (2000). In vivo magnetic resonance imaging of transgene expression. Nat Med. 6:351-355.
19. Manabe Y, Longley C, Furmanski P (1986). High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier. Biochim Biophys Acta. 883:460-467.
20. Gohr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J (1993). The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging. Invest Radiol. 28:789-795.
21. Williams RF, Siegle RL, Salman M, Ollom CM, Cortinas NS, Simmons AM, Pierce BL, Orang-Khadivi K, Chaudhuri AR (1996). Substrate modification of melanin polymers to Increase effectiveness of contrast agents for magnetic resonance imaging. Acad Radial. 3:S365-S369.
22. Curtet C, Maton F, Havet T, Slinkin M, Mishra A, Chatal JF, Muller RN (1998). Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to ami-CEA F(ab′)2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol. 33:752-761.
23. Kresse M, Wagner S, Pfefferer D, Lawaczeck R, Elste V, Semmler W (1998). Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med. 40:236-242.
24. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC (1998). Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 4:623-626.
25. Moats RA, Fraser SE, Meade TJ (1997). A "smart" magnetic resonance Imaging agent that reports on specific enzymatic activity. Angew Chem, Int Ed. 36:726-731.
26. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 18:321-325.
27. Lauffer RB (1987). Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev. 87:901-927.
28. 2- to everything else. Magn Res Med. 22:183-190.
29. Gimbrone MA, Jr, Cotran RS (1975), Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest. 33:16-27.
30. Gimbrone MA, Jr (1976). Culture of vascular endothelium. Prog Hemostasis Thromb. 3:1-28.
31. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA, Jr (1987). Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA. 84:9238-9242.
32. Adams JC (1992). Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem. 40:1457-1463.
33. von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgil A (1997). Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem. 45:1455-1459.
34. Marzola P, Cannistraro S (1986). Influence of paramagnetic ions bound to human serum albumin on water 1HNMR relaxation times. Physiol Chem Phys Med NMR. 18:263-273.
35. Jenkins BG, Armstrong E, Lauffer RB (1991). Site-specific water proton relaxation enhancement of iron(III) chelates noncovalently bound to human serum albumin. Magn Reson Med, 17:164-178.
36. Smith CW (1993). Leukocyte-endothelial cell interactions. Semin Hematol. 30:45-53.
37. Yoshida M, Gimbrone MA, Jr (1997). Novel roles for E-selectin in endothelial-leukocyte adhesion. Ann NY Acad Sci. 811:493-497.
38. Gimbrone MA, Jr., Topper JN, Nagel T, Anderson KR. Garcia-Cardena G (2000). Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci. 902:230-239.